Early-Phase Clinical Trials for Blood Cell Therapies (R01)
The summary for the Early-Phase Clinical Trials for Blood Cell Therapies (R01) Federal Grant is detailed below.
It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section.
If these sections are incomplete, please visit the website of the government agency that is offering this grant.
| Federal Grant Title: | EARLY-PHASE CLINICAL TRIALS FOR BLOOD CELL THERAPIES (R01) |
| Federal Agency Name: | National Institutes of Health |
| Program Name: | Blood Diseases and Resources Research |
| Grant Categories: | Health |
| CFDA Number: | 93.839 |
| Funding Opportunity Number: | PAR-11-204 |
| Posted Date: | Apr 20, 2011 |
| Creation Date: | Apr 20, 2011 |
| Original Application Deadline: | Jan 07, 2013 |
| Current Application Deadline: | Jan 07, 2013 |
| Archive Date: | Feb 07, 2013 |
| Total Program Funding: | Information not provided |
| Maximum Federal Grant Award: | Information not provided |
| Minimum Federal Grant Award: | Information not provided |
| Expected Number of Awards: | Information not provided |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are not allowed.
- Grant Description
- This FOA issued by the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions and organizations for the purpose of supporting early-phase clinical trials i.e., first-in-human, phase I, or phase II trialsto evaluate innovative and novel cell therapies to treat blood diseases and/or to improve the outcome of hematopoietic stem cell transplantations.
- Link to Full Grant Announcement
-
http://grants.nih.gov/grants/guide/pa-files/par-11-204.html
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV] - Similar Government Grants
- • Erythropoiesis: Components and Mechanisms (R01)
- • Selected Topics in Transfusion Medicine (R01)
- • Selected Topics in Transfusion Medicine (R21)
- • Trans-Agency Research Consortium for Trauma-Induced Coagulopathy (TACTIC) (UM1)
- • Excellence in Hemoglobinopathies Research Award (EHRA) (U54)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Clinical Hematology Research Career Development Program (K12)
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- More Grants from the National Institutes of Health
- • NIAMS Clinical Trial Outcome Instrument Development Grant Program (U01)
- • Biophysical and Biomechanical Aspects of Embryonic Development (R01)
- • Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- • Dual Purpose with Dual Benefit: Research in Biomedicine and Agriculture Using Agricultural...
- • MARC Undergraduate Student Training in Academic Research (U-STAR) National Research Servic...